ProQR Therapeutics N.V. (PRQR)
NASDAQ: PRQR · IEX Real-Time Price · USD
1.645
-0.005 (-0.30%)
At close: Jul 2, 2024, 4:00 PM
1.650
+0.005 (0.30%)
After-hours: Jul 2, 2024, 4:09 PM EDT
ProQR Therapeutics Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for ProQR Therapeutics stock have an average target of 3.38, with a low estimate of 2.00 and a high estimate of 5.00. The average target predicts an increase of 105.47% from the current stock price of 1.65.
Analyst Consensus: Strong Buy
* Price targets were last updated on May 10, 2024.
Analyst Ratings
The average analyst rating for PRQR stock from 4 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 3 | 3 | 3 | 3 | 3 | 1 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 6 | 6 | 6 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $5 | Strong Buy | Reiterates | $5 | +203.95% | May 10, 2024 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $2.5 | Strong Buy | Maintains | $2.5 | +51.98% | May 10, 2024 |
| Citigroup | Citigroup | Hold Maintains $1.8 → $2 | Hold | Maintains | $1.8 → $2 | +21.58% | Apr 18, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $5 | Strong Buy | Reiterates | $5 | +203.95% | Mar 14, 2024 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $2 → $2.5 | Strong Buy | Maintains | $2 → $2.5 | +51.98% | Mar 14, 2024 |
Financial Forecast
Revenue This Year
22.47M
from 9.53M
Increased by 135.93%
Revenue Next Year
21.72M
from 22.47M
Decreased by -3.34%
EPS This Year
-0.47
from -0.35
EPS Next Year
-0.58
from -0.47
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 53.2M | 44.8M | 20.2M | 14.0M | 136.0M |
| Avg | 22.5M | 21.7M | 14.4M | 8.1M | 48.1M |
| Low | 4.6M | 7.7M | 8.9M | n/a | n/a |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 458.9% | 99.2% | -6.8% | -3.4% | 1,579.7% |
| Avg | 135.9% | -3.3% | -33.5% | -43.9% | 494.0% |
| Low | -51.8% | -65.7% | -59.2% | - | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -0.33 | -0.28 | -0.42 |
| Avg | -0.47 | -0.58 | -0.66 |
| Low | -0.62 | -0.85 | -0.90 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.